Rilutek

Rilutek® (Riluzole tablets) is the first ALS drug approved by the FDA for the treatment of ALS. This glutamate-blocking drug has been proven effective in well-controlled studies using survival as an end point. 

For further information about Rilutek®, please talk to your physician or visit www.rilutek.com.